Որոնման արդյունքները - Judith Balmañà
- Ցուցադրվում են 1 - 20 արդյունքները 85
- Գնացեք Հաջորդ էջ
-
1
BRCA in breast cancer: ESMO Clinical Practice Guidelines Judith Balmañà, Orland Dı́ez, Isabel T. Rubio, M. Castiglione
Հրապարակվել է 2010Artigo -
2
-
3
-
4
-
5
Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† Neda Stjepanovic, Leticia Moreira, Fátima Carneiro, Francesc Balaguer, Andrés Cervantes, Judith Balmañà, Erika Martinelli
Հրապարակվել է 2019Artigo -
6
Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines Eduardo Vilar, Maurizio Scaltriti, Judith Balmañà, Cristina Saura, Marta Guzmán, Joaquı́n Arribas, José Baselga, Josep Tabernero
Հրապարակվել է 2008Artigo -
7
Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening Shani Paluch‐Shimon, Fátima Cardoso, Cristiana Sessa, Judith Balmañà, Maria João Cardoso, Fiona J. Gilbert, Elżbieta Senkus
Հրապարակվել է 2016Artigo -
8
Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy Charlie Gourley, Judith Balmañà, Jonathan A. Ledermann, Violeta Serra, Rebecca Dent, Sibylle Loibl, Éric Pujade-Lauraine, Simon J. Boulton
Հրապարակվել է 2019Revisão -
9
Validation and Extension of the PREMM1,2 Model in a Population-Based Cohort of Colorectal Cancer Patients Francesc Balaguer, Judith Balmañà, Sergi Castellví–Bel, Ewout W. Steyerberg, Montserrat Andreu, Xavier Llor, Rodrigo Jover, Sapna Syngal, Antoni Castells
Հրապարակվել է 2007Artigo -
10
-
11
-
12
A decade of clinical development of PARP inhibitors in perspective Joaquı́n Mateo, Christopher J. Lord, Violeta Serra, Andrew Tutt, Judith Balmañà, Marta Castroviejo‐Bermejo, Cristina Cruz, Ana Oaknin, Stan B. Kaye, Johann S. de Bono
Հրապարակվել է 2019Revisão -
13
Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) Marc Tischkowitz, Judith Balmañà, William D. Foulkes, Paul A. James, Joanne Ngeow, Rita K. Schmutzler, Nicoleta Voian, Myra J. Wick, Douglas R. Stewart, Tuya Pal
Հրապարակվել է 2021Artigo -
14
Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Soc... Deepak Vangala, Estelle Cauchin, Judith Balmañà, Lucjan Wyrwicz, Eric Van Cutsem, Ulrich Güller, Antoni Castells, Fátima Carneiro, Pascal Hammel, Michel Ducreux, Jean‐Luc Van Laethem, Tamara Matysiak‐Budnik, Wolff Schmiegel
Հրապարակվել է 2018Artigo -
15
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing Judith Balmañà, Laura DiGiovanni, Pragna Gaddam, Michael F. Walsh, Joseph Vijai, Zsofia K. Stadler, Katherine L. Nathanson, Judy E. Garber, Fergus J. Couch, Kenneth Offit, Mark E. Robson, Susan M. Domchek
Հրապարակվել է 2016Artigo -
16
Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma Ricardo Errazquin, Estela Carrasco, Sonia Del Marro, Anna Suñol, Jorge Peral, Jessica Ortiz, Juan Carlos Rubio, Carmen Segrelles, Marta Dueñas, Alicia Garrido-Aranda, Martina Álvarez, Cristina Beléndez, Judith Balmañà, Ramón García‐Escudero
Հրապարակվել է 2023Artigo -
17
Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing. Charlie F Rowlands, Sophie Allen, Judith Balmañà, Susan M. Domchek, D. Gareth Evans, Helen Hanson, Nicoline Hoogerbrugge, Philip James, K.L. Nathanson, Mark E. Robson, Marc Tischkowitz, William D. Foulkes, Clare Turnbull
Հրապարակվել է 2024Revisão -
18
Comparison of the clinical prediction model PREMM<sub>1,2,6</sub>and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer Fay Kastrinos, Ewout W. Steyerberg, Judith Balmañà, Rowena Mercado, Steven Gallinger, Robert W. Haile, Graham Casey, John L. Hopper, Loı̈c Le Marchand, Noralane M. Lindor, Polly A. Newcomb, Stephen N. Thibodeau, Sapna Syngal
Հրապարակվել է 2012Artigo -
19
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance Yifan Wang, Andrea J. Bernhardy, Joseph Nacson, John J. Krais, Yinfei Tan, Émmanuelle Nicolas, Marc R. Radke, Elizabeth Handorf, Alba Llop‐Guevara, Judith Balmañà, Elizabeth M. Swisher, Violeta Serra, Suraj Peri, Neil Johnson
Հրապարակվել է 2019Artigo -
20
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort Serena Masciari, Deborah Dillon, M Rath, Mark E. Robson, Jeffrey N. Weitzel, Judith Balmañà, Stephen B. Gruber, James M. Ford, David Euhus, Alexandra Lebensohn, Melinda L. Telli, Stephen Pochebit, Georgios Lypas, Judy E. Garber
Հրապարակվել է 2012Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Medicine
Cancer
Biology
Gene
Internal medicine
Genetics
Oncology
Breast cancer
Mutation
Germline mutation
Cancer research
Poly ADP ribose polymerase
Polymerase
Germline
Ovarian cancer
Gynecology
Colorectal cancer
PARP inhibitor
DNA mismatch repair
DNA repair
Environmental health
Genotype
Olaparib
Population
Computational biology
PALB2
Pathology
Biochemistry
DNA
Genetic testing